...
首页> 外文期刊>Scandinavian journal of clinical and laboratory investigation. >Nitric oxide test during cardiac catheterization decreases the serum concentrations of S100B protein in adult patients with idiopathic pulmonary hypertension.
【24h】

Nitric oxide test during cardiac catheterization decreases the serum concentrations of S100B protein in adult patients with idiopathic pulmonary hypertension.

机译:成年特发性肺动脉高压患者在心脏导管插入过程中进行的一氧化氮测试可降低S100B蛋白的血清浓度。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: Cardiac catheterization (CC) is a life-threatening procedure in adult patients. Complicated by idiopathic arterial pulmonary hypertension (IPAH), there is a potential risk of central nervous system (CNS) damage. We measured serum levels of a well-established brain damage marker, namely S100B, collected before, during and after CC in adult patients in whom the nitric oxide (NO) test had been performed. MATERIAL AND METHODS: In 12 adult patients who had undergone CC for IPAH diagnosis, we recorded clinical and standard monitoring procedures (laboratory variables and echocardiographic patterns) and serum concentrations of S100B before (time 0), during (time 1) and after the NO test (time 2) and at 24 h after (time 3) the procedure in samples obtained from the systemic and pulmonary circulation. Patients were subdivided into NO test responders (n=6) and non-responders (n=6). Neurological evaluation was performed at admission and at discharge from hospital. RESULTS: Adult patients subjected to CCshowed no overt neurological injury at discharge from hospital. No significant differences (p > 0.05 for all) in S100B serum levels between groups at times 0, 1 and 3 have been shown independently from the sampling site. It was noteworthy that the concentration of protein in the responders group at time 2 was significantly decreased (p < 0.05, for all) compared to the responder group and to baseline values. A significant correlation was found between arterial oxygen partial pressure and individual S100B concentration in the pulmonary and systemic bloodstream in the entire study group (R = -0.66 and R = 0.71, respectively; p < 0.05, for both). CONCLUSIONS: The data suggest that S100B protein assessment, as well as the NO test, may be useful when monitoring possible CNS damage during CC in patients with IPAH, and may also be valuable in relation to brain functions, especially when performed as an emergency procedure in severely hypoxic patients.
机译:目的:心脏导管插入术(CC)是成年患者的致命生命。合并特发性动脉肺动脉高压(IPAH),存在中枢神经系统(CNS)损害的潜在风险。我们测量了在进行过一氧化氮(NO)测试的成年患者CC之前,期间和之后收集的完善的脑损伤标记物S100B的血清水平。材料与方法:在12例接受CCAH进行IPAH诊断的成年患者中,我们记录了临床和标准监测程序(实验室变量和超声心动图)以及NO前(时间0),期间(时间1)和NO后的S100B血清浓度测试(时间2)以及在从全身和肺循环获得的样品中进行此程序(时间3)后的24小时(时间3)。将患者分为无反应者(n = 6)和无反应者(n = 6)。入院时和出院时进行神经系统评估。结果:接受CC治疗的成年患者出院时未显示明显的神经系统损伤。在0、1、3时刻,独立于采样部位,各组之间的S100B血清水平无显着差异(对于所有p> 0.05)。值得注意的是,与反应者组和基线值相比,反应者组在时间2的蛋白质浓度显着降低(对于所有情况,p <0.05)。在整个研究组中,发现动脉血氧分压与肺和全身血中单个S100B浓度之间存在显着相关性(分别为R = -0.66和R = 0.71;两者均p <0.05)。结论:数据表明,S100B蛋白评估以及NO检测在监测IPAH患者CC期间CCS可能发生的CNS损伤时可能有用,并且在脑功能方面也可能是有价值的,尤其是作为紧急程序进行时在严重缺氧的患者中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号